The Brussels Liver Research to Valorisation Consortium (B-Liver), integrates the complementary liver cell biology, pathology and toxicology expertise of Vrije Universiteit Brussels’ liver research groups of IVTD and LIVR.
B-Liver’s mission is primarily grounded in established models and technology, but also extends into higher-risk emerging innovations towards liver modelling, toxicity prediction and therapeutic strategies in liver disease.
What we do?
- Collaborative R&D
- Liver cell based testing, modelling and analytical services
- Diverse liver cell based products, including stem cell models, spheroid models, HT compatible, co-cultures… etc
- Liver biology and toxicology consultancy
- Public health and consumer safety consultancy
- 3R alternative methodologies technologies and dissemination platforms
B-Liver Technology Platforms
Click on the diagram to go that section
News & Events
News
MathieuVinken
Horizon 2020 – start 1/5/2021
Providing a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals.
Leo van Grunsven
FWO SBO – start 1/10/2020
Tamara Vanhaecke
Horizon 2020 TWINNING - start 1/10/2020
TWINALT: Twinning towards excellence in alternative methods for toxicity assessment
Events
HepaSCREEN
Knowledge for Growth 2020 (digital edition)
HepaSCREEN highlighted in TTO Showcase
EvoMed
Joery De Kock (Invited Speaker)
Gene Therapy session “Reaching beyond the limits of nature to cure inherited metabolic disorders of the liver” & Panel discussion "Immunogenicity for gene therapy"
